It is acknowledged that the diagnosis of ZES is becoming more challenging, primarily due to increasing unreliability of commercial gastrin assays; the lack of availability of secretin to perform secretin provocative tests, where indicated; and the widespread use of PPIs (8). The gene discussed is SCT; the disease is Zollinger-Ellison syndrome.